John Connor
Associate Professor of Microbiology Researcher, National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University
Schools
- Boston University
Links
Biography
Boston University
Dr. Connor’slaboratory studies several cytoplasmically replicating viruses. They are particularly interested in understanding the response of the circulating immune system to challenge by hemorrhagic fever virus infection. His collaborations with researchers at USAMRIID have led to studies on genome-wide responses of non-human primates to infection with Ebola, Lassa, or Marburg virus, CDC category A pathogens with a high mortality rate. They have identified a number of up regulated inflammation-related pathways. With funding from the National Institute of Allergy and Infectious Diseases, Dr. Connor studies the tricks that viruses use to dominate their cellular hosts. He has been working collaboratively with researchers at BU‘s National Emerging Infectious Disease Laboratory (NEIDL) and at other research institutions, with a particular focus on the Ebola virus.
Read about executive education
Cases
Advances in Ebola Diagnosis and Treatment
May 22, 2017
WCAI quoting John Connor, School of Medicine “Ebola is back…” Expert quote: “This vaccine is still in development.” View full article.
View full article
Facing Down the World’s Deadliest Pathogens in a BSL4 Lab
April 5, 2016
Scientific American John Connor, School of Medicine, NEIDL Ebola, smallpox, plague—the rogue’s gallery of highly infectious deadly pathogens is frighteningly long and their potential for havoc is great, which is why they can only be studied within the tightly controlled confines of a biosafety level 4 (BSL4) facility… View full article quoting expert John Connor
View full article
OraSure in race to make much-needed rapid Ebola test
May 16, 2015
The Morning Call John Connor, School of Medicine, NEIDL The Ebola epidemic has cooled to a simmer in West Africa, but the race to provide the technology needed to thwart the next outbreak is just heating up… Expert quote: “There is now the recognition that diagnostics is something that really needs to be paid attention […]
View full article
$1 million Mass. grant bolsters hunt for Ebola test
December 17, 2014
Boston Globe (subscription required) John Connor, School of Medicine, NEIDL A Cambridge nonprofit, one of several groups worldwide racing to develop a rapid test for the Ebola virus, received a boost Tuesday when state officials gave the organization $1 million to help bring its finger-prick device to market… Expert quote: “What’s clear is there is not […]
View full article
Why Haven’t We Found a Cure for Ebola in Boston?
December 9, 2014
Boston.com John Connor, School of Medicine, NEIDL In West Africa alone, the World Health Organization reports that the current Ebola outbreak— the most severe on record—has killed more than 6,000 out of the 17,000 people who have contracted it. Here in Boston, you could literally bump into someone working on a cure, but it’s a process […]
View full article
Early Signs of Ebola-Like Diseases Found
November 11, 2014
LiveScience John Connor, School of Medicine, NEIDL Tests for Ebola virus currently cannot identify the disease until after people show symptoms, and so individuals exposed to the virus have to wait to see if they are infected… Expert quote: “It looks like there are some very early and distinct ways in which the immune system […]
View full article
LED Device Will Detect Ebola Cheaply and Quickly
November 8, 2014
Newsweek Selim Ünlü, College of Engineering John Connor, School of Medicine, NEIDL Four years into a five-year project to develop a rapid hemorrhagic virus detection technology, the deadliest outbreak of Ebola hemorrhagic fever in history struck. For the Boston University research team working on the SP-IRIS device (single particle interferometric reflectance imaging sensor), it’s a […]
View full article
Lack of Mobile Ebola Test Harms Effort in West Africa
October 31, 2014
Bloomberg John Connor, School of Medicine, NEIDL The largest Ebola diagnostic lab in Liberia, housed in a shabby brick building 65 miles (105 kilometers) east of the capital Monrovia, can test about 80 to 90 blood samples a day… Expert quote: “It seems like everybody’s got an Ebola test these days. It may be something where there is the […]
View full article
Harvard prof develops fast, cheap prototype Ebola test
October 28, 2014
Boston Herald James Collins, College of Engineering John Connor, School of Medicine, NEIDL A Harvard researcher and his team have developed a prototype Ebola test that could detect the virus in 30 minutes and cost less than $1 to reproduce… View full article quoting experts James Collins and John Connor
View full article
U.S. plans 21-day monitoring of people who arrive from Ebola-stricken nations
October 22, 2014
Washington Post John Connor, School of Medicine, NEIDL Every airline passenger who arrives in the United States from one of the three West African nations hardest hit by Ebola will be monitored by state and local health authorities for 21 days, the Centers for Disease Control and Prevention said Wednesday… Expert quote: “What a logistical […]
View full article
Other experts
Jo-Ann McArthur
President, fisheye corporation Jo-Ann has built brands at Molson, Procter & Gamble, Unilever and Cadillac Fairview. She lectures at and is founding Chair of the Sponsorship Marketing Council of Canada.
Natalya Vinokurova
Natalya Vinokurova is an Assistant Professor of Management at the Wharton School of the University of Pennsylvania. She graduated cum laude from Harvard College, where she studied Psychology, and she received her MPhil and PhD in Business Administration from the NYU Stern School. Her dissertation...
Heibatollah Sami
Heibatollah Sami has over 25 years of teaching and professional experience in accounting. He was Professor of Accounting at Temple University before joining Lehigh University as Sue and Eugene Mercy Professor of Accounting in Fall of 2005. He had worked at Temple University since 1984, where he t...
Looking for an expert?
Contact us and we'll find the best option for you.